• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人类HIV-1感染中的体液免疫反应可清除病毒复制的初始爆发并预防疾病进展。

Humoral immune responses in human HIV-1 infection clearance of initial burst of virus replication and protection against disease progression.

作者信息

Goudsmit J

机构信息

Human Retrovirus Laboratory, Academic Medical Center, Amsterdam, The Netherlands.

出版信息

Int Rev Immunol. 1992;8(1):65-81. doi: 10.3109/08830189209056642.

DOI:10.3109/08830189209056642
PMID:1374113
Abstract

An attempt is made to summarize the evidence that humoral immune responses in natural HIV-1 infection play a role in clearance of the initial burst of replication as well as in protection against rapid disease progression. Therefore, the so-called "asymptomatic carrier state" was defined on the basis of immunological characteristics, such as CD4+ cell number, CD45RA-CD29+ cell number, CD4+ proliferative responses to anti-CD3 mAbs and soluble activation markers, as well as virological characteristics such as the state of the viral genome in the cell, levels of genomic RNA production, antigenemia, viremia and virus phenotype. During natural infection two major classes HIV-1 neutralizing and cell-fusion inhibiting antibodies are elicited. One population directed against mostly continuous epitopes localized in the third variable domain (V3) of the envelope and one against discontinuous epitopes of the envelope. The last population blocks gp120-CD4 attachment, the first does not. The role of each of these populations of functional antibodies, in the clearance of viremia and the maintenance of the asymptomatic carrier state is discussed.

摘要

本文试图总结相关证据,即自然HIV-1感染中的体液免疫反应在清除初始爆发性复制以及预防疾病快速进展方面发挥作用。因此,所谓的“无症状携带者状态”是根据免疫特征(如CD4+细胞数量、CD45RA-CD29+细胞数量、CD4+对抗CD3单克隆抗体和可溶性激活标志物的增殖反应)以及病毒学特征(如细胞内病毒基因组状态、基因组RNA产生水平、抗原血症、病毒血症和病毒表型)来定义的。在自然感染过程中,会产生两大类HIV-1中和抗体和细胞融合抑制抗体。一类主要针对包膜第三可变区(V3)中大多连续的表位,另一类针对包膜的不连续表位。后一类抗体阻断gp120-CD4结合,前一类则不然。本文讨论了这些功能性抗体群体在清除病毒血症和维持无症状携带者状态中的作用。

相似文献

1
Humoral immune responses in human HIV-1 infection clearance of initial burst of virus replication and protection against disease progression.人类HIV-1感染中的体液免疫反应可清除病毒复制的初始爆发并预防疾病进展。
Int Rev Immunol. 1992;8(1):65-81. doi: 10.3109/08830189209056642.
2
How antibodies block HIV infection: paths to an AIDS vaccine.
Trends Biochem Sci. 1992 May;17(5):191-6. doi: 10.1016/0968-0004(92)90265-b.
3
HIV-1 proteins in infected cells determine the presentation of viral peptides by HLA class I and class II molecules and the nature of the cellular and humoral antiviral immune responses--a review.感染细胞中的HIV-1蛋白决定了HLA I类和II类分子对病毒肽的呈递以及细胞和体液抗病毒免疫反应的性质——综述
Virus Genes. 1994 Jul;8(3):249-70. doi: 10.1007/BF01704519.
4
Influence of N-linked glycans in V4-V5 region of human immunodeficiency virus type 1 glycoprotein gp160 on induction of a virus-neutralizing humoral response.1型人类免疫缺陷病毒糖蛋白gp160的V4-V5区域中N-连接聚糖对诱导病毒中和性体液反应的影响。
J Acquir Immune Defic Syndr Hum Retrovirol. 1996 Jul;12(3):213-20. doi: 10.1097/00042560-199607000-00001.
5
HIV-1 envelope-elicited neutralizing antibody titres correlate with protection and virus load in chimpanzees.HIV-1包膜诱导的中和抗体滴度与黑猩猩的保护作用及病毒载量相关。
Vaccine. 1994 Sep;12(12):1141-8. doi: 10.1016/0264-410x(94)90185-6.
6
CD4+ T-lymphocyte lines developed from HIV-1-seropositive patients recognize different epitopes within the V3 loop.从HIV-1血清阳性患者中培养出的CD4 + T淋巴细胞系可识别V3环内的不同表位。
J Acquir Immune Defic Syndr Hum Retrovirol. 1996 Feb 1;11(2):128-36. doi: 10.1097/00042560-199602010-00003.
7
Clonal analysis of T-cell responses to the HIV-1 envelope proteins in AIDS vaccine recipients.艾滋病疫苗接种者中T细胞对HIV-1包膜蛋白反应的克隆分析。
AIDS Res Hum Retroviruses. 1992 Aug;8(8):1349-52. doi: 10.1089/aid.1992.8.1349.
8
Augmentation of human immunodeficiency virus type 1 neutralizing antibody by priming with gp160 recombinant vaccinia and boosting with rgp160 in vaccinia-naive adults. The NIAID AIDS Vaccine Clinical Trials Network.在未感染过牛痘的成年人中,先用重组牛痘病毒gp160进行初免,再用rgp160进行加强免疫,以增强1型人类免疫缺陷病毒中和抗体。美国国立过敏与传染病研究所艾滋病疫苗临床试验网络。
J Infect Dis. 1993 Mar;167(3):533-7. doi: 10.1093/infdis/167.3.533.
9
HIV/AIDS Vaccine Candidates Based on Replication-Competent Recombinant Poxvirus NYVAC-C-KC Expressing Trimeric gp140 and Gag-Derived Virus-Like Particles or Lacking the Viral Molecule B19 That Inhibits Type I Interferon Activate Relevant HIV-1-Specific B and T Cell Immune Functions in Nonhuman Primates.基于表达三聚体gp140和Gag衍生病毒样颗粒的复制能力重组痘病毒NYVAC-C-KC或缺乏抑制I型干扰素的病毒分子B19的HIV/AIDS候选疫苗,在非人灵长类动物中激活相关的HIV-1特异性B和T细胞免疫功能。
J Virol. 2017 Apr 13;91(9). doi: 10.1128/JVI.02182-16. Print 2017 May 1.
10
Differences in the antibody response to human immunodeficiency virus-1 envelope glycoprotein (gp160) in infected laboratory workers and vaccinees.受感染的实验室工作人员和疫苗接种者对人类免疫缺陷病毒1型包膜糖蛋白(gp160)抗体反应的差异。
J Clin Invest. 1993 May;91(5):1987-96. doi: 10.1172/JCI116420.

引用本文的文献

1
A single amino acid substitution in hypervariable region 5 of the envelope protein of feline immunodeficiency virus allows escape from virus neutralization.猫免疫缺陷病毒包膜蛋白高变区5中的单个氨基酸取代可使其逃避病毒中和作用。
J Virol. 1993 Apr;67(4):2202-8. doi: 10.1128/JVI.67.4.2202-2208.1993.